Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test

<div>Sensitivity of ColoDefense in detecting colorectal cancer across stages I-IV with serum samples: (a) positive detection rates for NED individuals and all stages of colorectal cancer and (b) ROC curves for the ColoDefense in detecting colorectal cancer.</div>

Disease Markers

fig2

Figure 2

Figure 2: Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test 